Tekla Life Sciences Investors (HQL)

Tekla Life Sciences Investors is a closed-end fund that invests in public and private companies in the life sciences industry. Tekla Capital Management LLC, based in Boston, serves as Investment Adviser to the Fund.

Company profile

Ticker

HQL

Exchange

NYSE

Website

www.teklacap.com/funds/hql/fund/fund-information

CEO

Daniel R. Omstead

Incorporated

Massachusetts

Location

Massachusetts

Fiscal year end

Sep 30

Sector

Finance and Insurance > Securities and Commodity Exchanges

Former names

H&Q LIFE SCIENCES INVESTORS

SEC CIK

0000884121

IRS number

43147016

HQL stock data

1M 1Y 5Y

News

From Benzinga Pro

Stocks That Hit 52-Week Lows On Monday

13 Jun 22

During Monday's trading, 1214 companies set new 52-week lows.

Stocks That Hit 52-Week Lows On Friday

10 Jun 22

On Friday, 422 stocks made new 52-week lows.

Tekla Life Sciences's Ex-Dividend Date Is Thursday, Here's What You Need To Know

23 May 22

Wednesday marks the last chance for investors to receive the next dividend payout from Tekla Life Sciences (NYSE:HQL).

Press releases

From Benzinga Pro

Tekla Healthcare Opportunities Fund Paid Distribution

30 Jun 22

On June 30, 2022, Tekla Healthcare Opportunities Fund paid a monthly distribution of $0.1125 per share. It is currently estimated that this distribution is derived from net investment income, net realized short-term

Tekla Life Sciences Investors Paid Distribution

30 Jun 22

On June 30, 2022, Tekla Life Sciences Investors paid a distribution of $0.35 per share. It is currently estimated that this distribution is derived from net realized long-term capital gains and return of capital or

Tekla World Healthcare Fund Paid Distribution

30 Jun 22

On June 30, 2022, Tekla World Healthcare Fund paid a monthly distribution of $0.1167 per share. It is currently estimated that this distribution is derived from net investment income and return of capital or other

Tekla Healthcare Investors Paid Distribution

30 Jun 22

Tekla Healthcare Opportunities Fund Paid Distribution

31 May 22

Funds

Data from SEC filings

Series	Ticker	%Monthly Return ?			$Assets	#Holdings	As of
TEKLA LIFE SCIENCES INVESTORS	–	-5.62	-7.11	0.43	448.41M	142	Mar 2022

Calendar

2 May 22

4 Jul 22

30 Sep 22

Recent insider trades

HQL insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
23 Mar 22	Kathleen Goetz	Shares of Beneficial Interest	Buy	Acquire P	No	No	16.27	92.308	1.5K	685.308
26 Jan 22	Kathleen Goetz	Shares of Beneficial Interest	Buy	Acquire P	No	No	17.5441	593	10.4K	593
11 Aug 21	Daniel R Omstead	Shares of Beneficial Interest	Buy	Acquire P	No	No	21.63	6,403	138.5K	146,489.44

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.

Institutional ownership, Q1 2022

HQL institutional ownership history Ownership history

20.7% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	63	67	-6.0%
Opened positions	8	10	-20.0%
Closed positions	12	12	–
Increased positions	21	30	-30.0%
Reduced positions	20	15	+33.3%

13F shares	Current	Prev Q	Change
Total value	90.2M	104.71M	-13.9%
Total shares	5.19M	5.45M	-4.7%
Total puts	0	0
Total calls	0	0
Total put/call ratio	–	–	–

Largest owners	Shares	Value	Change
First Trust Portfolios	1.58M	$30.31M	0.0%
Needham Investment Management	450K	$7.44M	0.0%
MS Morgan Stanley	432.95K	$7.16M	+14.1%
Flagship Harbor Advisors	339.18K	$5.61M	+1.3%
Advisors Asset Management	325.64K	$5.39M	-12.5%
WFC Wells Fargo & Co.	281.06K	$4.65M	-7.0%
LPLA LPL Financial	195.16K	$3.23M	-6.0%
Lazard Asset Management	185.33K	$3.07M	0.0%
UBS UBS Group AG - Registered Shares	109.29K	$1.81M	-10.3%
AUB Atlantic Union Bankshares	96.54K	$1.6M	-2.6%

Largest transactions	Shares	Bought/sold	Change
CNS Cohen & Steers	66.19K	-59.7K	-47.4%
Raymond James & Associates	24.21K	-57.17K	-70.3%
Stephens	10.43K	-55.14K	-84.1%
MS Morgan Stanley	432.95K	+53.41K	+14.1%
Advisors Asset Management	325.64K	-46.32K	-12.5%
Atria Wealth Solutions	40.03K	+40.03K	NEW
NEXT Financial	0	-38.56K	EXIT
Kingsview Wealth Management	0	-32.65K	EXIT
Wolverine Asset Management	24.63K	+24.63K	NEW
WFC Wells Fargo & Co.	281.06K	-21.3K	-7.0%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Financial report summary

Management Discussion

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: accrual, Alleghany, Asia, assessment, Boeing, car, certification, Chevron, China, chip, computer, Connecticut, dealership, delivery, development, difficult, divestiture, driver, earliest, emergence, escalating, exceptionally, expenditure, extend, finalized, geopolitical, Germany, greater, inbound, inflation, intend, intended, intercompany, lack, lag, larger, mandatory, MAX, mitigate, modest, modified, multiple, notably, Notwithstanding, oil, Pacific, packaging, pause, pay, penalty, pension, potential, preliminarily, receipt, refinancing, replaced, resumption, retrospective, retrospectively, revised, revision, show, shutdown, slight, subcontracted, System, traffic, transition, trend, twenty, unallocated, uneven, unplanned, upstream, vast, wage, welfare, York

Removed: absorb, actuarial, aggressive, ASC, assuming, call, Central, charged, Codification, collateral, collected, competitive, complex, comprise, comprising, considerably, consisted, continuing, contractually, Council, counterparty, Cove, declared, determine, Dominion, experienced, expire, FASB, firm, flat, footprint, illiquid, improving, initial, intensely, lumber, malpractice, MLMIC, newspaper, November, occur, Organization, partnership, people, Point, post, recreational, reevaluate, Reliability, remote, renewal, residual, resize, restocking, restructure, restructuring, settled, slowdown, steel, strike, treat, typically, undiscounted, unexpired, vaccinate, Water

From filing 10-Q 2022 Q1

Financial reports

View all